Completed PHASE3 INTERVENTIONAL 1-arm NCT01077960

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Phase III, Multi-Center, Open, 12-Week, Follow-up Safety and Efficacy Study of Serostim® in Subjects With Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS)

Sponsor: EMD Serono

Conditions Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Interventions Serostim

Updated 7 times since 2017 Last updated: Aug 4, 2013 Started: Feb 28, 2005 Primary completion: Jan 31, 2006 Completion: Jan 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome and is currently completed. EMD Serono leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EMD Serono

Data source: EMD Serono

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Annandale, United States , Atlanta, United States , Austin, United States , Birmingham, United States , Boston, United States , Chicago, United States , Fort Lauderdale, United States , Los Angeles, United States , Miami, United States , Minneapolis, United States and 12 more locations